PPT-Cardiometabolic Risk: Diabetes Management

David J Albrecht DO Heart amp Vascular 2018 Winter Conference Cardiovascular risk m odification in relation to current diabetes management therapies Case study highlighting the therapeutic decisions . Prof. John Betteridge, MD. University College London. London, United Kingdom. Cardio. Diabetes . Master. . Class. Asian. . chapter. January. 28-30 2011, . Shanghai. Slide lecture prepared and held by:. A . Potential Predictor For Metabolic. Syndrome In Normal Weight Individuals. Julia Humphrey. Central Washington University. Overview. Introduction. Metabolic Syndrome. MONW & metabolic . syndrome. A lifetime risk challenge. Priorities in the management . of . type 2 diabetes:. Past, present and future. Sir George Alberti, MD. Diabetes UK Chairman. Newcastle. , United Kingdom. Cardio. Diabetes . A lifetime risk challenge. Priorities in the management . of . type 2 diabetes:. Past, present and future. Sir George Alberti, MD. Diabetes UK Chairman. Newcastle. , United Kingdom. Cardio. Diabetes . 1. AACE Comprehensive Diabetes Care: Glucose Goals . Parameter. Treatment Goal for . Nonpregnant. Adults. A1C (%). . Individualize based on age, comorbidities, and duration of disease*. ≤6.5 for most. for Type 2 Diabetes. 1. AACE Outpatient Glucose Targets for Nonpregnant Adults. Parameter. Treatment Goal. A1C, %. Individualize on the basis of age, comorbidities,. . duration of disease, and hypoglycemia. 1. Obesity. Management of Common Comorbidities in Diabetes. 2. 3. 4. More Than Two Thirds of US Adults Are Overweight or Obese. 5. *2014 rate of overweight not reported in . Flegal. et al 2016; 2012 rate carried over based on historic stability of overweight prevalence.. Rashmi Kudesia, . M.D. M.Sc.. Icahn School of Medicine at Mount . Sinai. November . 18, 2015. Objectives. To highlight the dilemmas in PCOS management in the . primary . care . setting. To address barriers . Gynecologist & obstetrician . 5-7% . of . pregnancies. 90% GDM & 10% diabetes type 1&2 . . Insulin . resistance in pregnancy in favor of : . placental . secretion of . GH,CRH,PL,progestron. Maternal Child and Reproductive Health Fellow . September 7, 2016. Disclosures. I have nothing to disclose . Objectives. At the end of this lecture, you should be able to: . Define gestational diabetes, overt diabetes of pregnancy, diabetes mellitus type II . Prof Kausik Ray, . BSc (. hons. ), . MBChB. , MRCP, MD, MPhil (. Cantab. ), FACC, FESC, FAHA. Professor of Cardiovascular Disease Prevention. St Georges University of London. Honorary Consultant Cardiologist St Georges Hospital. A Barquilla García Brief update on diabetes for general practitioners — 57 — Brief update on diabetes for general practitioners A Barquilla García EAP Trujillo (Medical Centre of Herguijue Nurse Practitioner. Inpatient Glycemic Management Team. University of Alabama at Birmingham. Birmingham, AL. Disclosure to Participants. Notice of Requirements For Successful Completion. Please refer to learning goals and objectives. for HCSWs. Katharine Ramage. Diabetes MCN Professional Education Lead/DSN. Learning Outcomes. Develop an understanding of the different types of diabetes, risk factors for developing diabetes, how it can present and how it is diagnosed.